US Patent Issued to NantCell on Oct. 20 for "Peptide therapeutics against SARS-COV-2 spike protein" (California Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,191, issued on Oct. 20, was assigned to NantCell Inc. (Culver City, Calif.).

"Peptide therapeutics against SARS-COV-2 spike protein" was invented by Jay Gardner Nelson (Sherman Oaks, Calif.), Oleksandr Buzko (Oak Park, Calif.), Wendy M. Higashide (Rosemead, Calif.), Kayvan Niazi (Agoura Hills, Calif.), Clifford Anders Olson (Long Beach, Calif.), Patrick Soon-Shiong (Los Angeles) and Shiho Tanaka (Redondo Beach, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Proteinaceous therapeutics, such as antibodies and fusion proteins, for preventing, reducing the occurrence of, and/or treating a SARS-CoV-2 infection in a subject are provided herein. The...